Enzymatic passaging of human embryonic stem cells alters central carbon metabolism and glycan abundance
- 18 August 2015
- journal article
- research article
- Published by Wiley in Biotechnology Journal
- Vol. 10 (10) , 1600-1611
Abstract
To realize the potential of human embryonic stem cells (hESCs) in regenerative medicine and drug discovery applications, large numbers of cells that accurately recapitulate cell and tissue function must be robustly produced. Previous studies have suggested that genetic instability and epigenetic changes occur as a consequence of enzymatic passaging. However, the potential impacts of such passaging methods on the metabolism of hESCs have not been described. Using stable isotope tracing and mass spectrometry‐based metabolomics, we have explored how different passaging reagents impact hESC metabolism. Enzymatic passaging caused significant decreases in glucose utilization throughout central carbon metabolism along with attenuated de novo lipogenesis. In addition, we developed and validated a method for rapidly quantifying glycan abundance and isotopic labeling in hydrolyzed biomass. Enzymatic passaging reagents significantly altered levels of glycans immediately after digestion but surprisingly glucose contribution to glycans was not affected. These results demonstrate that there is an immediate effect on hESC metabolism after enzymatic passaging in both central carbon metabolism and biosynthesis. HESCs subjected to enzymatic passaging are routinely placed in a state requiring re‐synthesis of biomass components, subtly influencing their metabolic needs in a manner that may impact cell performance in regenerative medicine applications.Keywords
Funding Information
- CIRM (RB5-07356)
- NIH (R01-CA188652-2)
This publication has 59 references indexed in Scilit:
- Metabolic Plasticity in Stem Cell Homeostasis and DifferentiationCell Stem Cell, 2012
- UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cellsThe EMBO Journal, 2011
- An Emerging Role of Degrading Proteinases in Hypertension and the Metabolic Syndrome: Autodigestion and Receptor CleavageCurrent Hypertension Reports, 2011
- Metabolic oligosaccharide engineering with N‐Acyl functionalized ManNAc analogs: Cytotoxicity, metabolic flux, and glycan‐display considerationsBiotechnology and Bioengineering, 2011
- The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogrammingCell Research, 2011
- Somatic Oxidative Bioenergetics Transitions into Pluripotency-Dependent Glycolysis to Facilitate Nuclear ReprogrammingCell Metabolism, 2011
- Dynamic Changes in the Copy Number of Pluripotency and Cell Proliferation Genes in Human ESCs and iPSCs during Reprogramming and Time in CultureCell Stem Cell, 2011
- Metabolism, Cell Surface Organization, and DiseaseCell, 2009
- Modeling Hybridoma Cell Metabolism Using a Generic Genome-Scale Metabolic Model of Mus musculusBiotechnology Progress, 2008
- The endothelial glycocalyx: composition, functions, and visualizationPflügers Archiv - European Journal of Physiology, 2007